Derbyshire County Council is set to approve its plans for a 25-acre solar farm between Chesterfield and Bolsover ...

Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis ...

Eli Lilly reported total tirzepatide sales that rocketed 272% year over year to $11 billion during the first nine months of ...

Singulair, a popular asthma medication, could be linked to severe side effects, including suicide, a study from the FDA found ...

Primary tumor sites included the pancreas (15 patients), ileum (6 patients), lung (3 patients ... A pilot study of pembrolizumab and peptide receptor radionuclide therapy for patients with ...

Compared with placebo, sodium zirconium cyclosilicate was associated with less need to lower or discontinue spironolactone.

It’s definitely doing something that’s concerning,” one scientist said about reported side effects of the drug.

TCR immunotherapy is emerging as a promising, targeted approach for treating solid tumours and other indications.

Icotrokinra binds to the IL-23 receptor with single-digit picomolar affinity and demonstrated potent ... The information provided on PharmiWeb.com is designed to support, not replace, the relationship ...

The Company expects to enroll patients at investigator sites in North America, Europe, and the Asia-Pacific region ... ZW191 is an antibody-drug conjugate that is engineered to target a protein called ...

Oral peptide with biologics-like high potency and spectrum of activity against three therapeutically relevant dimeric forms of IL-17 (AA, AF and FF)IND enabling studies underway, with Phase I ...